As shown in Table 2, in particular, the vast majority of the cohort of patients with G2 tumours with high YB-1 expression at the tumour IF, exhibited a statistically significant, shorter, DSS compared with patients with low YB-1 protein expression. The gene discussed is YBX1; the disease is neoplasm.